Literature DB >> 23729173

Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.

Klaudia U Hunter1, Oliver E Lee, Teresa H Lyden, Marc J Haxer, Felix Y Feng, Mathew Schipper, Francis Worden, Mark E Prince, Scott A McLean, Gregory T Wolf, Carol R Bradford, Douglas B Chepeha, Avraham Eisbruch.   

Abstract

BACKGROUND: The purpose of this study was to assess aspiration pneumonia (AsPn) rates and predictors after chemo-irradiation for head and neck cancer.
METHODS: The was a prospective study of 72 patients with stage III to IV oropharyngeal cancer treated definitively with intensity-modulated radiotherapy (IMRT) concurrent with weekly carboplatin and paclitaxel. AsPn was recorded prospectively and dysphagia was evaluated longitudinally through 2 years posttherapy by observer-rated (Common Toxicity Criteria version [CTCAE]) scores, patient-reported scores, and videofluoroscopy.
RESULTS: Sixteen patients (20%) developed AsPn. Predictive factors included T classification (p = .01), aspiration detected on videofluoroscopy (videofluoroscopy-asp; p = .0007), and patient-reported dysphagia (p = .02-.0003), but not observer-rated dysphagia (p = .4). Combining T classification, patient reported dysphagia, and videofluoroscopy-asp, provided the best predictive model.
CONCLUSION: AsPn continues to be an under-reported consequence of chemo-irradiation for head and neck cancer. These data support using patient-reported dysphagia to identify high-risk patients requiring videofluoroscopy evaluation for preventive measures. Reducing videofluoroscopy-asp rates, by reducing swallowing structures radiation doses and by trials reducing treatment intensity in patients predicted to do well, are likely to reduce AsPn rates.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  IMRT; aspiration pneumonia; dysphagia; head and neck cancer; oropharyngeal cancer

Mesh:

Year:  2013        PMID: 23729173      PMCID: PMC4144677          DOI: 10.1002/hed.23275

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  22 in total

Review 1.  Aspiration pneumonitis and aspiration pneumonia.

Authors:  P E Marik
Journal:  N Engl J Med       Date:  2001-03-01       Impact factor: 91.245

2.  A penetration-aspiration scale.

Authors:  J C Rosenbek; J A Robbins; E B Roecker; J L Coyle; J L Wood
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

3.  Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer.

Authors:  Avraham Eisbruch; Teresa Lyden; Carol R Bradford; Laura A Dawson; Marc J Haxer; Amy E Miller; Theodoros N Teknos; Douglas B Chepeha; Norman D Hogikyan; Jeffrey E Terrell; Gregory T Wolf
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

4.  Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer.

Authors:  Guido B van den Broek; Alfons J M Balm; Michiel W M van den Brekel; Michael Hauptmann; Jan H Schornagel; Coen R N Rasch
Journal:  Radiother Oncol       Date:  2006-10-19       Impact factor: 6.280

Review 5.  Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer.

Authors:  David I Rosenthal; Jan S Lewin; Avraham Eisbruch
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

6.  Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.

Authors:  Ethan Basch; Alexia Iasonos; Tiffani McDonough; Allison Barz; Ann Culkin; Mark G Kris; Howard I Scher; Deborah Schrag
Journal:  Lancet Oncol       Date:  2006-11       Impact factor: 41.316

7.  Aspiration occurence during chemoradiation for head and neck cancer.

Authors:  Nam P Nguyen; Herbert J Smith; Suresh Dutta; Alan Alfieri; Debra North; Phuc D Nguyen; Howard Lee; Tomas Martinez; Claire Lemanski; Adir Ludin; Ly M Nguyen; Sabah Sallah
Journal:  Anticancer Res       Date:  2007 May-Jun       Impact factor: 2.480

8.  Patient self-perceptions of swallowing difficulties as compared to expert ratings of videofluorographic studies.

Authors:  Ruiying Ding; Jeri A Logemann
Journal:  Folia Phoniatr Logop       Date:  2008-03-13       Impact factor: 0.849

9.  The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.

Authors:  Kenneth Jensen; Anders Bonde Jensen; Cai Grau
Journal:  Radiother Oncol       Date:  2006-03-09       Impact factor: 6.280

10.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

View more
  33 in total

1.  Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis.

Authors:  Katherine A Hutcheson; Zhannat Nurgalieva; Hui Zhao; Gary B Gunn; Sharon H Giordano; Mihir K Bhayani; Jan S Lewin; Carol M Lewis
Journal:  Head Neck       Date:  2018-12-07       Impact factor: 3.147

2.  Penetration-Aspiration: Is Their Detection in FEES ® Reliable Without Video Recording?

Authors:  Christiane Hey; Petra Pluschinski; Raissa Pajunk; Anas Almahameed; Lara Girth; Robert Sader; Timo Stöver; Yevgen Zaretsky
Journal:  Dysphagia       Date:  2015-05-06       Impact factor: 3.438

3.  What Are We Really Measuring? A Content Comparison of Swallowing Outcome Measures for Head and Neck Cancer Based on the International Classification of Functioning, Disability and Health (ICF).

Authors:  Rebecca Louise Nund; Bena Brown; Elizabeth Celeste Ward; Julia Maclean; Justin Roe; Joanne M Patterson; Rosemary Martino
Journal:  Dysphagia       Date:  2019-04-03       Impact factor: 3.438

4.  Pretreatment factors associated with functional oral intake and feeding tube use at 1 and 6 months post-radiotherapy (+/- chemotherapy) for head and neck cancer.

Authors:  Molly K Barnhart; Elizabeth C Ward; Bena Cartmill; Rachelle A Robinson; Virginia A Simms; Sophie J Chandler; Elea T Wurth; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-06       Impact factor: 2.503

5.  Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.

Authors:  Ryan P Goepfert; Jan S Lewin; Martha P Barrow; G Brandon Gunn; C David Fuller; Beth M Beadle; Adam S Garden; David I Rosenthal; Merrill S Kies; Vassiliki Papadimitrakopoulou; Stephen Y Lai; Neil D Gross; David L Schwartz; Katherine A Hutcheson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-06-15       Impact factor: 7.038

6.  Expiratory muscle strength training for radiation-associated aspiration after head and neck cancer: A case series.

Authors:  Katherine A Hutcheson; Martha P Barrow; Emily K Plowman; Stephen Y Lai; Clifton David Fuller; Denise A Barringer; George Eapen; Yiqun Wang; Rachel Hubbard; Sarah K Jimenez; Leila G Little; Jan S Lewin
Journal:  Laryngoscope       Date:  2017-08-22       Impact factor: 3.325

7.  European white paper: oropharyngeal dysphagia in head and neck cancer.

Authors:  Laura W J Baijens; Margaret Walshe; Leena-Maija Aaltonen; Christoph Arens; Reinie Cordier; Patrick Cras; Lise Crevier-Buchman; Chris Curtis; Wojciech Golusinski; Roganie Govender; Jesper Grau Eriksen; Kevin Hansen; Kate Heathcote; Markus M Hess; Sefik Hosal; Jens Peter Klussmann; C René Leemans; Denise MacCarthy; Beatrice Manduchi; Jean-Paul Marie; Reza Nouraei; Claire Parkes; Christina Pflug; Walmari Pilz; Julie Regan; Nathalie Rommel; Antonio Schindler; Annemie M W J Schols; Renee Speyer; Giovanni Succo; Irene Wessel; Anna C H Willemsen; Taner Yilmaz; Pere Clavé
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-12-19       Impact factor: 2.503

8.  Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification Based on MBS DIGEST and Clinical CTCAE Grades.

Authors:  Ryan P Goepfert; Jan S Lewin; Martha P Barrow; Carla L Warneke; Clifton D Fuller; Stephen Y Lai; Randal S Weber; Katherine A Hutcheson
Journal:  Dysphagia       Date:  2017-08-23       Impact factor: 3.438

9.  Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.

Authors:  Ryan P Goepfert; Jan S Lewin; Martha P Barrow; C David Fuller; Stephen Y Lai; Juhee Song; Brian P Hobbs; G Brandon Gunn; Beth M Beadle; David I Rosenthal; Adam S Garden; Merrill S Kies; Vali A Papadimitrakopoulou; David L Schwartz; Katherine A Hutcheson
Journal:  Laryngoscope       Date:  2016-07-21       Impact factor: 3.325

10.  Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors.

Authors:  Katherine A Hutcheson; Martha P Barrow; Carla L Warneke; Yiqun Wang; George Eapen; Stephen Y Lai; Denise A Barringer; Emily K Plowman; Jan S Lewin
Journal:  Laryngoscope       Date:  2017-11-08       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.